Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 188

1.

Hypertrophic cardiomyopathy with dynamic obstruction and high left ventricular outflow gradients associated with paradoxical apical ballooning.

Sherrid MV, Riedy K, Rosenzweig B, Ahluwalia M, Arabadjian M, Saric M, Balaram S, Swistel DG, Reynolds HR, Kim B.

Echocardiography. 2019 Jan;36(1):47-60. doi: 10.1111/echo.14212. Epub 2018 Dec 12.

PMID:
30548699
2.

Upfront Magnetic Resonance Imaging-Guided Stereotactic Laser-Ablation in Newly Diagnosed Glioblastoma: A Multicenter Review of Survival Outcomes Compared to a Matched Cohort of Biopsy-Only Patients.

Mohammadi AM, Sharma M, Beaumont TL, Juarez KO, Kemeny H, Dechant C, Seas A, Sarmey N, Lee BS, Jia X, Fecci PE, Baehring J, Moliterno J, Chiang VL, Ahluwalia MS, Kim AH, Barnett GH, Leuthardt EC.

Neurosurgery. 2018 Nov 23. doi: 10.1093/neuros/nyy449. [Epub ahead of print]

PMID:
30476325
3.

Recent advances in managing brain metastasis.

Kotecha R, Gondi V, Ahluwalia MS, Brastianos PK, Mehta MP.

F1000Res. 2018 Nov 9;7. pii: F1000 Faculty Rev-1772. doi: 10.12688/f1000research.15903.1. eCollection 2018. Review.

4.

Global immune fingerprinting in glioblastoma patient peripheral blood reveals immune-suppression signatures associated with prognosis.

Alban TJ, Alvarado AG, Sorensen MD, Bayik D, Volovetz J, Serbinowski E, Mulkearns-Hubert EE, Sinyuk M, Hale JS, Onzi GR, McGraw M, Huang P, Grabowski MM, Wathen CA, Ahluwalia MS, Radivoyevitch T, Kornblum HI, Kristensen BW, Vogelbaum MA, Lathia JD.

JCI Insight. 2018 Nov 2;3(21). pii: 122264. doi: 10.1172/jci.insight.122264. [Epub ahead of print]

5.

Novel Systemic Treatments for Brain Metastases From Lung Cancer.

Thapa B, Lauko A, Desai K, Venur VA, Ahluwalia MS.

Curr Treat Options Neurol. 2018 Sep 27;20(11):48. doi: 10.1007/s11940-018-0533-2. Review.

PMID:
30259236
6.

Phase II Study of Iniparib with Concurrent Chemoradiation in Patients with Newly Diagnosed Glioblastoma.

Blakeley JO, Grossman SA, Chi AS, Mikkelsen T, Rosenfeld MR, Ahluwalia MS, Nabors LB, Eichler A, Ribas IG, Desideri S, Ye X; Adult Brain Tumor Consortium.

Clin Cancer Res. 2019 Jan 1;25(1):73-79. doi: 10.1158/1078-0432.CCR-18-0110. Epub 2018 Aug 21.

PMID:
30131387
7.

Management of Brain Metastases in the New Era of Checkpoint Inhibition.

Lauko A, Thapa B, Venur VA, Ahluwalia MS.

Curr Neurol Neurosci Rep. 2018 Aug 18;18(10):70. doi: 10.1007/s11910-018-0877-8. Review.

PMID:
30121715
8.

Expression of LC3B and FIP200/Atg17 in brain metastases of breast cancer.

Hashemi-Sadraei N, Müller-Greven GM, Abdul-Karim FW, Ulasov I, Downs-Kelly E, Burgett ME, Lauko A, Qadan MA, Weil RJ, Ahluwalia MS, Du L, Prayson RA, Chao ST, Budd TG, Barnholtz-Sloan J, Nowacki AS, Keri RA, Gladson CL.

J Neurooncol. 2018 Nov;140(2):237-248. doi: 10.1007/s11060-018-2959-5. Epub 2018 Aug 9.

PMID:
30094720
9.

Integrating imaging modalities for diagnosing cardiac amyloidosis.

Ahluwalia M, Reyentovich A, Donnino R, Phillips LM.

J Nucl Cardiol. 2018 Jul 9. doi: 10.1007/s12350-018-1342-4. [Epub ahead of print] No abstract available.

PMID:
29987632
10.

Laser ablation after stereotactic radiosurgery: a multicenter prospective study in patients with metastatic brain tumors and radiation necrosis.

Ahluwalia M, Barnett GH, Deng D, Tatter SB, Laxton AW, Mohammadi AM, Leuthardt E, Chamoun R, Judy K, Asher A, Essig M, Dietrich J, Chiang VL.

J Neurosurg. 2018 Apr 1:1-8. doi: 10.3171/2017.11.JNS171273. [Epub ahead of print]

PMID:
29726782
11.

Correlation Between the Residual Tumor Volume, Extent of Tumor Resection, and O6-Methylguanine DNA Methyltransferase Status in Patients with Glioblastoma.

Sharma M, Bellamkonda S, Mohapatra S, Meola A, Jia X, Mohammadi A, Angelov L, Barnett GH, Vogelbaum M, Ahluwalia MS.

World Neurosurg. 2018 Aug;116:e147-e161. doi: 10.1016/j.wneu.2018.04.134. Epub 2018 Apr 27.

PMID:
29709748
12.

First-in-human evaluation of the Cleveland Multiport Catheter for convection-enhanced delivery of topotecan in recurrent high-grade glioma: results of pilot trial 1.

Vogelbaum MA, Brewer C, Barnett GH, Mohammadi AM, Peereboom DM, Ahluwalia MS, Gao S.

J Neurosurg. 2018 Apr 1:1-10. doi: 10.3171/2017.10.JNS171845. [Epub ahead of print]

PMID:
29652233
13.

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Central Nervous System Metastases from Non-Small Cell Lung Cancer.

Ahluwalia MS, Becker K, Levy BP.

Oncologist. 2018 Oct;23(10):1199-1209. doi: 10.1634/theoncologist.2017-0572. Epub 2018 Apr 12. Review.

PMID:
29650684
14.

TET-2 up-regulation is associated with the anti-inflammatory action of Vicenin-2.

Hassan N, Ali A, Withycombe C, Ahluwalia M, Al-Nasseri RH, Tonks A, Morris K.

Cytokine. 2018 Aug;108:37-42. doi: 10.1016/j.cyto.2018.03.016. Epub 2018 Mar 19.

PMID:
29567563
15.

The Evolving Landscape of Brain Metastasis.

Valiente M, Ahluwalia MS, Boire A, Brastianos PK, Goldberg SB, Lee EQ, Le Rhun E, Preusser M, Winkler F, Soffietti R.

Trends Cancer. 2018 Mar;4(3):176-196. doi: 10.1016/j.trecan.2018.01.003. Epub 2018 Feb 21. Review.

PMID:
29506669
16.

An Excellent Clinical Outcome with Stereotactic Radiosurgery in a Geriatric Patient with Multiple and Recurrent Brain Metastases.

Thapa B, Borghei-Razavi H, M Mohammadi A, Ahluwalia M.

Cureus. 2017 Dec 22;9(12):e1979. doi: 10.7759/cureus.1979.

17.

Risk Factors for Malignant Transformation of Low-Grade Glioma.

Murphy ES, Leyrer CM, Parsons M, Suh JH, Chao ST, Yu JS, Kotecha R, Jia X, Peereboom DM, Prayson RA, Stevens GHJ, Barnett GH, Vogelbaum MA, Ahluwalia MS.

Int J Radiat Oncol Biol Phys. 2018 Mar 15;100(4):965-971. doi: 10.1016/j.ijrobp.2017.12.258. Epub 2017 Dec 21.

PMID:
29485076
18.

Modulatory role of GSTT1 and GSTM1 in Punjabi agricultural workers exposed to pesticides.

Ahluwalia M, Kaur A.

Environ Sci Pollut Res Int. 2018 Apr;25(12):11981-11986. doi: 10.1007/s11356-018-1459-7. Epub 2018 Feb 15.

PMID:
29450776
19.

Targeted therapy of brain metastases: latest evidence and clinical implications.

Di Lorenzo R, Ahluwalia MS.

Ther Adv Med Oncol. 2017 Dec;9(12):781-796. doi: 10.1177/1758834017736252. Epub 2017 Nov 15. Review.

20.

Impact of pemetrexed on intracranial disease control and radiation necrosis in patients with brain metastases from non-small cell lung cancer receiving stereotactic radiation.

Cagney DN, Martin AM, Catalano PJ, Reitman ZJ, Mezochow GA, Lee EQ, Wen PY, Weiss SE, Brown PD, Ahluwalia MS, Arvold ND, Tanguturi SK, Haas-Kogan DA, Alexander BM, Redig AJ, Aizer AA.

Radiother Oncol. 2018 Mar;126(3):511-518. doi: 10.1016/j.radonc.2018.01.005. Epub 2018 Feb 3.

PMID:
29398153
21.

Radiogenomic analysis of hypoxia pathway is predictive of overall survival in Glioblastoma.

Beig N, Patel J, Prasanna P, Hill V, Gupta A, Correa R, Bera K, Singh S, Partovi S, Varadan V, Ahluwalia M, Madabhushi A, Tiwari P.

Sci Rep. 2018 Jan 8;8(1):7. doi: 10.1038/s41598-017-18310-0.

22.

Systemic therapy for brain metastases.

Venur VA, Karivedu V, Ahluwalia MS.

Handb Clin Neurol. 2018;149:137-153. doi: 10.1016/B978-0-12-811161-1.00011-6. Review.

PMID:
29307351
23.

Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group.

Alexander BM, Brown PD, Ahluwalia MS, Aoyama H, Baumert BG, Chang SM, Gaspar LE, Kalkanis SN, Macdonald DR, Mehta MP, Soffietti R, Suh JH, van den Bent MJ, Vogelbaum MA, Wefel JS, Lee EQ, Wen PY; Response Assessment in Neuro-Oncology (RANO) group.

Lancet Oncol. 2018 Jan;19(1):e33-e42. doi: 10.1016/S1470-2045(17)30692-7. Review.

PMID:
29304360
24.

Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group.

Camidge DR, Lee EQ, Lin NU, Margolin K, Ahluwalia MS, Bendszus M, Chang SM, Dancey J, de Vries EGE, Harris GJ, Hodi FS, Lassman AB, Macdonald DR, Peereboom DM, Schiff D, Soffietti R, van den Bent MJ, Wefel JS, Wen PY.

Lancet Oncol. 2018 Jan;19(1):e20-e32. doi: 10.1016/S1470-2045(17)30693-9. Review.

PMID:
29304358
25.

Whole-Brain Radiotherapy for Brain Metastases: Evolution or Revolution?

Brown PD, Ahluwalia MS, Khan OH, Asher AL, Wefel JS, Gondi V.

J Clin Oncol. 2018 Feb 10;36(5):483-491. doi: 10.1200/JCO.2017.75.9589. Epub 2017 Dec 22.

26.

Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial.

Stupp R, Taillibert S, Kanner A, Read W, Steinberg D, Lhermitte B, Toms S, Idbaih A, Ahluwalia MS, Fink K, Di Meco F, Lieberman F, Zhu JJ, Stragliotto G, Tran D, Brem S, Hottinger A, Kirson ED, Lavy-Shahaf G, Weinberg U, Kim CY, Paek SH, Nicholas G, Bruna J, Hirte H, Weller M, Palti Y, Hegi ME, Ram Z.

JAMA. 2017 Dec 19;318(23):2306-2316. doi: 10.1001/jama.2017.18718. Erratum in: JAMA. 2018 May 1;319(17):1824.

27.

Multi-institutional competing risks analysis of distant brain failure and salvage patterns after upfront radiosurgery without whole brain radiotherapy for brain metastasis.

McTyre E, Ayala-Peacock D, Contessa J, Corso C, Chiang V, Chung C, Fiveash J, Ahluwalia M, Kotecha R, Chao S, Attia A, Henson A, Hepel J, Braunstein S, Chan M.

Ann Oncol. 2018 Feb 1;29(2):497-503. doi: 10.1093/annonc/mdx740.

PMID:
29161348
28.

A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913.

Chinnaiyan P, Won M, Wen PY, Rojiani AM, Werner-Wasik M, Shih HA, Ashby LS, Michael Yu HH, Stieber VW, Malone SC, Fiveash JB, Mohile NA, Ahluwalia MS, Wendland MM, Stella PJ, Kee AY, Mehta MP.

Neuro Oncol. 2018 Apr 9;20(5):666-673. doi: 10.1093/neuonc/nox209.

PMID:
29126203
29.

Treatment of Glioblastoma in Older Adults.

Braun K, Ahluwalia MS.

Curr Oncol Rep. 2017 Oct 26;19(12):81. doi: 10.1007/s11912-017-0644-z. Review.

PMID:
29075865
30.

Changing Treatment Paradigms for Brain Metastases From Melanoma-Part 2: When and How to Use the New Systemic Agents.

Venur VA, Funchain P, Kotecha R, Chao ST, Ahluwalia MS.

Oncology (Williston Park). 2017 Sep 15;31(9):659-67. Review.

31.

Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02.

Galanis E, Anderson SK, Miller CR, Sarkaria JN, Jaeckle K, Buckner JC, Ligon KL, Ballman KV, Moore DF Jr, Nebozhyn M, Loboda A, Schiff D, Ahluwalia MS, Lee EQ, Gerstner ER, Lesser GJ, Prados M, Grossman SA, Cerhan J, Giannini C, Wen PY; Alliance for Clinical Trials in Oncology and ABTC.

Neuro Oncol. 2018 Mar 27;20(4):546-556. doi: 10.1093/neuonc/nox161.

PMID:
29016887
32.

Phase I Trial of Radiosurgery Dose Escalation Plus Bevacizumab in Patients With Recurrent/Progressive Glioblastoma.

Abbassy M, Missios S, Barnett GH, Brewer C, Peereboom DM, Ahluwalia M, Neyman G, Chao ST, Suh JH, Vogelbaum MA.

Neurosurgery. 2018 Sep 1;83(3):385-392. doi: 10.1093/neuros/nyx369.

PMID:
28973311
33.

Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.

Angelov L, Mohammadi AM, Bennett EE, Abbassy M, Elson P, Chao ST, Montgomery JS, Habboub G, Vogelbaum MA, Suh JH, Murphy ES, Ahluwalia MS, Nagel SJ, Barnett GH.

J Neurosurg. 2018 Aug;129(2):366-382. doi: 10.3171/2017.3.JNS162532. Epub 2017 Sep 22.

PMID:
28937324
34.

Macropinocytosis of Bevacizumab by Glioblastoma Cells in the Perivascular Niche Affects their Survival.

Müller-Greven G, Carlin CR, Burgett ME, Ahluwalia MS, Lauko A, Nowacki AS, Herting CJ, Qadan MA, Bredel M, Toms SA, Lathia JD, Hambardzumyan D, Sarkaria JN, Hamerlik P, Gladson CL.

Clin Cancer Res. 2017 Nov 15;23(22):7059-7071. doi: 10.1158/1078-0432.CCR-17-0249. Epub 2017 Sep 14.

35.

Prediction of new brain metastases after radiosurgery: validation and analysis of performance of a multi-institutional nomogram.

Ayala-Peacock DN, Attia A, Braunstein SE, Ahluwalia MS, Hepel J, Chung C, Contessa J, McTyre E, Peiffer AM, Lucas JT Jr, Isom S, Pajewski NM, Kotecha R, Stavas MJ, Page BR, Kleinberg L, Shen C, Taylor RB, Onyeuku NE, Hyde AT, Gorovets D, Chao ST, Corso C, Ruiz J, Watabe K, Tatter SB, Zadeh G, Chiang VLS, Fiveash JB, Chan MD.

J Neurooncol. 2017 Nov;135(2):403-411. doi: 10.1007/s11060-017-2588-4. Epub 2017 Aug 21.

36.

Changing Treatment Paradigms for Brain Metastases From Melanoma-Part 1: Diagnosis, Prognosis, Symptom Control, and Local Treatment.

Venur VA, Funchain P, Kotecha R, Chao ST, Ahluwalia MS.

Oncology (Williston Park). 2017 Aug 15;31(8):602-6. Review.

37.

Melanoma brain metastasis: the impact of stereotactic radiosurgery, BRAF mutational status, and targeted and/or immune-based therapies on treatment outcome.

Kotecha R, Miller JA, Venur VA, Mohammadi AM, Chao ST, Suh JH, Barnett GH, Murphy ES, Funchain P, Yu JS, Vogelbaum MA, Angelov L, Ahluwalia MS.

J Neurosurg. 2018 Jul;129(1):50-59. doi: 10.3171/2017.1.JNS162797. Epub 2017 Aug 11.

PMID:
28799876
38.

Novel therapeutic agents in the management of brain metastases.

Venur VA, Ahluwalia MS.

Curr Opin Oncol. 2017 Sep;29(5):395-399. doi: 10.1097/CCO.0000000000000393. Review.

PMID:
28787285
39.

First follow-up radiographic response is one of the predictors of local tumor progression and radiation necrosis after stereotactic radiosurgery for brain metastases.

Sharma M, Jia X, Ahluwalia M, Barnett GH, Vogelbaum MA, Chao ST, Suh JH, Murphy ES, Yu JS, Angelov L, Mohammadi AM.

Cancer Med. 2017 Sep;6(9):2076-2086. doi: 10.1002/cam4.1149. Epub 2017 Aug 4.

40.

Evidence for a role of TRIB3 in the regulation of megakaryocytopoiesis.

Butcher L, Ahluwalia M, Örd T, Johnston J, Morris RH, Kiss-Toth E, Örd T, Erusalimsky JD.

Sci Rep. 2017 Jul 27;7(1):6684. doi: 10.1038/s41598-017-07096-w.

41.

Cumulative Intracranial Tumor Volume and Number of Brain Metastasis as Predictors of Developing New Lesions After Stereotactic Radiosurgery for Brain Metastasis.

Sharma M, Jia X, Ahluwalia M, Barnett GH, Vogelbaum MA, Chao ST, Suh JH, Murphy ES, Yu JS, Angelov L, Mohammadi AM.

World Neurosurg. 2017 Oct;106:666-675. doi: 10.1016/j.wneu.2017.07.048. Epub 2017 Jul 19.

PMID:
28735139
42.

Intensity modulated radiation therapy with pulsed reduced dose rate as a reirradiation strategy for recurrent central nervous system tumors: An institutional series and literature review.

Murphy ES, Rogacki K, Godley A, Qi P, Reddy CA, Ahluwalia MS, Peereboom DM, Stevens GH, Yu JS, Kotecha R, Suh JH, Chao ST.

Pract Radiat Oncol. 2017 Nov - Dec;7(6):e391-e399. doi: 10.1016/j.prro.2017.04.003. Epub 2017 Apr 12.

PMID:
28666902
43.

Intracranial and Systemic Response to Alectinib in a Patient with RET-KIF5B Oncogenic Fusion.

Velcheti V, Ahluwalia M.

J Thorac Oncol. 2017 Jul;12(7):e98-e99. doi: 10.1016/j.jtho.2017.03.007. No abstract available.

44.

The Prognostic Role of Tumor Volume in the Outcome of Patients with Single Brain Metastasis After Stereotactic Radiosurgery.

Bennett EE, Angelov L, Vogelbaum MA, Barnett GH, Chao ST, Murphy ES, Yu JS, Suh JH, Jia X, Stevens GHJ, Ahluwalia MS, Mohammadi AM.

World Neurosurg. 2017 Aug;104:229-238. doi: 10.1016/j.wneu.2017.04.156. Epub 2017 May 3.

PMID:
28478250
45.

The risk of radiation necrosis following stereotactic radiosurgery with concurrent systemic therapies.

Kim JM, Miller JA, Kotecha R, Xiao R, Juloori A, Ward MC, Ahluwalia MS, Mohammadi AM, Peereboom DM, Murphy ES, Suh JH, Barnett GH, Vogelbaum MA, Angelov L, Stevens GH, Chao ST.

J Neurooncol. 2017 Jun;133(2):357-368. doi: 10.1007/s11060-017-2442-8. Epub 2017 Apr 22.

PMID:
28434110
46.

Management of hypertension in 2017: targets and therapies.

Ahluwalia M, Bangalore S.

Curr Opin Cardiol. 2017 Jul;32(4):413-421. doi: 10.1097/HCO.0000000000000408. Review.

PMID:
28346238
47.

Targeted Treatment of Brain Metastases.

Shonka N, Venur VA, Ahluwalia MS.

Curr Neurol Neurosci Rep. 2017 Apr;17(4):37. doi: 10.1007/s11910-017-0741-2. Review.

PMID:
28326470
48.

The impact of tumor biology on survival and response to radiation therapy among patients with non-small cell lung cancer brain metastases.

Miller JA, Kotecha R, Ahluwalia MS, Mohammadi AM, Suh JH, Barnett GH, Murphy ES, Vogelbaum MA, Angelov L, Chao ST.

Pract Radiat Oncol. 2017 Jul - Aug;7(4):e263-e273. doi: 10.1016/j.prro.2017.01.001. Epub 2017 Jan 5.

PMID:
28254368
49.

Overall survival and the response to radiotherapy among molecular subtypes of breast cancer brain metastases treated with targeted therapies.

Miller JA, Kotecha R, Ahluwalia MS, Mohammadi AM, Chao ST, Barnett GH, Murphy ES, Vogelbaum MA, Angelov L, Peereboom DM, Suh JH.

Cancer. 2017 Jun 15;123(12):2283-2293. doi: 10.1002/cncr.30616. Epub 2017 Feb 13.

50.

Patient-reported barriers and facilitators to antiretroviral adherence in sub-Saharan Africa.

Croome N, Ahluwalia M, Hughes LD, Abas M.

AIDS. 2017 Apr 24;31(7):995-1007. doi: 10.1097/QAD.0000000000001416. Review.

Supplemental Content

Loading ...
Support Center